课题基金 / 基金详情

Development of vinorelbine as a tablet based therapy to cure ectopic pregnancies

Development of vinorelbine as a tablet based therapy to cure ectopic pregnancies
开发长春瑞滨作为治疗异位妊娠的片剂疗法
批准号:
nhmrc : GNT1123274
负责人:
A/Pr Elgene Lim
金额:
$36.16万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 --

项目摘要

项目成果

A/Pr Elgene Lim的其他基金

相似基金

相关文献

中文摘要
翻译
如果妊娠植入输卵管,就会发生异位妊娠。它们可能是致命的,大多数是通过手术治疗的。我们将研究一种令人兴奋的可能性,即异位妊娠可以通过服用一次药片来治愈,而不是手术。我们将开展实验室研究和临床试验,为异位妊娠妇女提供长春瑞滨。
英文摘要
Ectopic pregnancies occur if the pregnancy implants in the Fallopian tube. They can be deadly and most are treated surgically. We will examine the exciting possibility that instead of surgery, ectopic pregnancies may be cured with a tablet taken just once. We will perform laboratory studies and a clinical trial, giving vinorelbine to women with ectopic pregnancies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pushing AR toward better outcomes in breast and prostate cancers
  • 批准号:
    nhmrc : 1145777
  • 项目类别:
    Project Grants
  • 资助金额:
    $67.53万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
Development of a novel and highly selective CDK4/6 inhibitor for treating cancer
  • 批准号:
    nhmrc : GNT1135682
  • 项目类别:
    Development Grants
  • 资助金额:
    $117.12万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
Development of a novel and highly selective CDK4/6 inhibitor for treating cancer
  • 批准号:
    nhmrc : 1135682
  • 项目类别:
    Development Grants
  • 资助金额:
    $79.19万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
Centre for Translational Breast Cancer Research (TransBCR): delivering laboratory discoveries to the clinic
  • 批准号:
    nhmrc : GNT1153049
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $249.64万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
海外基金